Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Cited by (1,000)

Items 301–400 of 1,000

1. Frontiers in cancer immunotherapy—a symposium report
   Jennifer Cable, Benjamin D. Greenbaum, Dana Pe’er, Catherine M. Bollard, Sofía Bruni, Matthew E. Griffin, James Patrick Allison, Catherine J. Wu, Sumit Kumar Subudhi, Elaine R. Mardis et al. · 2020 · Annals of the New York Academy of Sciences
2. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
   Amal Hasan, Ebaa Al‐Ozairi, Zahraa Albaqsumi, Rasheed Ahmad, Fahd Al‐Mulla · 2021 · ImmunoTargets and Therapy
3. Physiological and Pathophysiological Roles of Metabolic Pathways for NET Formation and Other Neutrophil Functions
   Darko Stojkov, Lea Gigon, Shuang Peng, Robert Łukowski, Peter Ruth, Alexander Viktorovich Karaulov, Albert Anatolyevich Rizvanov, Nickolai A. Barlev, Shída Yousefi, Hans‐Uwe Simon · 2022 · Frontiers in Immunology
4. COVID-19 versus HIT hypercoagulability
   Warkentin, Theodore E., Kaatz, Scott · 2020 · Thrombosis Research
5. Tackling COVID‐19 infection through complement‐targeted immunotherapy
   Sonata Jodele, Jörg Köhl · 2020 · British Journal of Pharmacology
6. Mechanisms of immunothrombosis in COVID-19
   Irina Portier, Robert A. Campbell, Frederik Denorme · 2021 · Current Opinion in Hematology
7. ACE2 Down-Regulation May Act as a Transient Molecular Disease Causing RAAS Dysregulation and Tissue Damage in the Microcirculatory Environment Among COVID-19 Patients
   Simone Gusmão Ramos, Bruna Amanda da Cruz Rattis, Giulia Ottaviani, MD, PhD, Mara Rúbia Nunes Celes, Eliane Pedra Dias · 2021 · American Journal Of Pathology
8. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
   Chisa Matsumoto, Shigeru Shibata, Takuya Kishi, Satoshi Morimoto, Masaki Mogi, Koichi I. Yamamoto, Kazuo Kobayashi, Masami Tanaka, Kei Asayama, Eiichiro Yamamoto et al. · 2022 · Hypertension Research
9. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection
   Pasquale Campana, Valentina Parisi, Dario Leosco, Debora Bencivenga, Fulvio Della Ragione, Adriana Borriello · 2020 · Cells
10. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients
    Anthony J. Maxwell, Jiahui Ding, Yuan You, Zhong Dong, Hussein Chehade, Ayesha B. Alvero, Yechiel Mor, Sorin Drăghici, Gil Mor · 2020 · Journal of Leukocyte Biology
11. NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
    Constant Gillot, Julien Favresse, François Mullier, Thomas Lecompte, Jean‐Michel Dogné, Jonathan Douxfils · 2021 · Frontiers in Pharmacology
12. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route
    Maiqueli Eduarda Dama Mingoti, Amanda Gollo Bertollo, Júlia Leão Batista Simões, Gabriel Rossi Francisco, Margarete Dulce Bagatini, Zuleide Maria Ignácio · 2022 · Journal of Molecular Neuroscience
13. The Impact of Cytokines on Neutrophils’ Phagocytosis and NET Formation during Sepsis—A Review
    Barbara Gierlikowska, Albert Stachura, Wojciech Gierlikowski, Urszula Anna Demkow · 2022 · International Journal of Molecular Sciences
14. NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and downstream pathways
    Yuxin Fei, Xiaozhi Wang, Fangyu Ning, Tiantian Qian, Jinfeng Cui, Xiaozhi Wang, Xiaozhi Wang · 2024 · Biomedicine & Pharmacotherapy
15. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
    Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, Massimiliano Galdiero, Claudio Napoli A · 2020 · British Journal of Anaesthesia
16. NETosis in Wound Healing: When Enough Is Enough
    Maurizio Sabbatini, Valeria Magnelli, Filippo Renò · 2021 · Cells
17. Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression
    Jaskaran Khinda, Naveed Zafar Janjua, Shannon S.Y. Cheng, Edwin R. van den Heuvel, Parveen Bhatti, Maryam Darvishian · 2020 · Journal of Medical Virology
18. The role of androgens in COVID-19
    Fatemeh Moradi, Behnaz Enjezab, Akram Ghadiri‐Anari · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
19. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset
    Juan Francisco Gutiérrez‐Bautista, Antonio Rodríguez-Nicolás, Antonio Rosales‐Castillo, Pilar Jiménez, Federico Garrido, Per O. Anderson, Francisco Ruiz‐Cabello, Miguel Ángel López‐Ruz · 2020 · Frontiers in Immunology
20. Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
    Jon Hazeldine, Janet M. Lord · 2020 · Frontiers in Immunology
21. COVID-19-associated liver injury: from bedside to bench
    Dongxiao Li, Xiangming Ding, Meng Xie, Dean Tian, Limin Xia · 2021 · Journal of Gastroenterology
22. The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection
    Allen W. Zhang, Sejal M. Morjaria, Anna Kaltsas, Tobias M. Hohl, Rekha Parameswaran, Dhruvkumar M. Patel, Wei Zhou, Jacqueline Predmore, Rocío Pérez-Johnston, Justin Jee et al. · 2021 · Clinical Infectious Diseases
23. Granulocyte‐colony stimulating factor in COVID ‐19: Is it stimulating more than just the bone marrow?
    Tamara Nawar, Sejal M. Morjaria, Anna Kaltsas, Dhruvkumar M. Patel, Rocío Pérez-Johnston, Anthony F. Daniyan, Sham Mailankody, Rekha Parameswaran · 2020 · American Journal of Hematology
24. Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
    Sara Lega, Samuele Naviglio, Stefano Volpi, Alberto Tommasini · 2020 · Vaccines
25. Potential role of platelets in COVID‐19: Implications for thrombosis
    Milka Koupenova · 2020 · Research and Practice in Thrombosis and Haemostasis
26. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19
    Madalina Elena Carter-Timofte, Sofie E. Jørgensen, Mette Ratzer Freytag, Michelle M. Thomsen, Nanna-Sophie Brinck Andersen, Ali Al-Mousawi, Alon Schneider Hait, Trine Hyrup Mogensen · 2020 · Frontiers in Immunology
27. Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection
    Allison Fialkowski, Yaël Gernez, Puneeta Arya, Katja Gabriele Weinacht, Thomas Bernard Kinane, Lael M. Yonker · 2020 · Pediatric Pulmonology
28. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review
    Vijay Viswanathan, Anudeep Puvvula, Ankush D. Jamthikar, Luca Saba, Amer M. Johri, Vasilios Kotsis, Narendra Nath Khanna, Surinder K. Dhanjil, Misha Majhail, Durga Prasanna Misra et al. · 2021 · World Journal of Diabetes
29. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses
    Hee Ho Park, Hyelim Kim, Han Sol Lee, Eun U Seo, Ji-Eun Kim, Jee-Hyun Lee, Yong‐Hyeon Mun, So-Yeol Yoo, Jiseon An, Mi‐Young Yun et al. · 2021 · Biomaterials
30. CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
    Pei‐Shan Sung, Shao-Ping Yang, Yu-Chun Peng, Cheng‐Pu Sun, Mi‐Hua Tao, Shie-Liang Edmond Hsieh · 2022 · Journal of Biomedical Science
31. Tissue factor in COVID-19-associated coagulopathy
    Saravanan Subramaniam, Hema Kothari, Markus Bosmann · 2022 · Thrombosis Research
32. Neutrophils and COVID-19: Nots, NETs, and knots
    Carl Nathan · 2020 · The Journal of Experimental Medicine
33. Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2
    Yi‐Hao Chan, Siew‐Wai Fong, Chek Meng Poh, Guillaume Carissimo, Nicholas Kim‐Wah Yeo, Siti Naqiah Amrun, Yun Shan Goh, Jackwee Lim, Weili Xu, Rhonda Sin‐Ling Chee et al. · 2021 · EMBO Molecular Medicine
34. COVID-19: a potential driver of immune-mediated breast cancer recurrence?
    Federica Francescangeli, Maria Laura De Angelis, Ann Zeuner · 2020 · Breast Cancer Research
35. In silico dynamics of COVID-19 phenotypes for optimizing clinical management
    Chrysovalantis Voutouri, Mohammad R. Nikmaneshi, Charles Corey Hardin, Ankit Bharat Patel, Ashish Verma, Melin Janardan Khandekar, Sayon Dutta, Triantafyllos Stylianopoulos, Lance L. Munn, Rakesh K. Jain · 2021 · Proceedings of the National Academy of Sciences
36. Neutrophils and neutrophil extracellular traps in oral health and disease
    Tae Sung Kim, Niki Maria Moutsopoulos · 2024 · Experimental & Molecular Medicine
37. Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury
    Astrid Obermayer, Lisa-Maria Jakob, Jasmin D. Haslbauer, Matthias Sebastian Matter, Alexandar Tzankov, Walter Stoiber · 2021 · Disease Markers
38. Cyclosporine A plus low‐dose steroid treatment in COVID‐19 improves clinical outcomes in patients with moderate to severe disease: A pilot study
    José Luis Gálvez-Romero, Oscar Palmeros-Rojas, F. A. Real‐Ramírez, Silvia Sánchez-Romero, R. Tome‐Maxil, María de Lourdes Patricia Ramírez-Sandoval, R. Olivos‐Rodríguez, S. E. Flores‐Encarnación, A. A. Cabrera‐Estrada, J. Ávila‐Morales et al. · 2020 · Journal of Internal Medicine
39. Radiotherapy and Cytokine Storm: Risk and Mechanism
    Chen Zhang, Zhenzhen Liang, Shumei Ma, Xiaodong Liu · 2021 · Frontiers in Oncology
40. Neutrophils as emerging protagonists and targets in chronic inflammatory diseases
    Kavita Rawat, Anju Shrivastava · 2022 · Inflammation Research
41. SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis
    Lihong Liu, Jie Du, Sidi Yang, Birong Zheng, Jian Shen, Jiacheng Huang, Liu Cao, Siyao Huang, Xue Liu, Liping Guo et al. · 2023 · Redox Biology
42. Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
    Shuangshuang Yang, Jie Xu, Yuting Dai, Shiwei Jin, Yan Sun, Jianfeng Li, Cheng-Lin Liu, Xiaolin Ma, Chen Hui Zhu, Lijuan Chen et al. · 2024 · Nature Communications
43. Is pregnancy an immunological contributor to severe or controlled COVID‐19 disease?
    Nazeeh N. Hanna, Monica Hanna, Surendra Sharma · 2020 · American Journal of Reproductive Immunology
44. The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
    Soheila Molaei, Masoomeh Dadkhah, Vahid Asghariazar, Chiman Karami, Elham Safarzadeh · 2020 · International Immunopharmacology
45. Epigenetic mechanisms influencing COVID-19
    Rwik Sen, Michael R. Garbati, Kevin F. Bryant, Yanan Lu · 2021 · Genome
46. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
    Norma A. Valdez-Cruz, E. García-Hernández, C. Espitia, L. Cobos-Marín, C. Altamirano, Carlos G. Bando-Campos, L. F. Cofas-Vargas, E. W. Coronado-Aceves, Ricardo A. González-Hernández, Pablo Hernández-Peralta et al. · 2021 · Microbial Cell Factories
47. Neutrophil extracellular traps have auto-catabolic activity and produce mononucleosome-associated circulating DNA
    Ekaterina Pisareva, Lucia Mihalovičová, Brice Pastor, Andrei Kudriavtsev, Alexia Mirandola, Thibault Mazard, Stéphanie Badiou, Ulrich A. Maus, Lena Ostermann, Julia Weinmann‐Menke et al. · 2022 · Genome Medicine
48. Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis
    Xin Su, Ariane Brassard, Alexandra Bartolomucci, Iqraa Dhoparee‐Doomah, Qian Qiu, Thupten Tsering, Ramin Rohanizadeh, Olivia Koufos, Betty Giannias, France Bourdeau et al. · 2023 · Journal of Extracellular Vesicles
49. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers
    Vanesa Seery, Silvina Raiden, Silvia Algieri, Nicolás Grisolía, Daniela Filippo, Norberto De Carli, Sandra Di Lalla, Héctor Cairoli, María José Chiolo, Claudia Meregalli et al. · 2021 · EBioMedicine
50. Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology
    Giuseppe Milone, Claudia Bellofiore, Salvatore Leotta, Giulio Antonio Milone, Alessandra Cupri, Andrea Duminuco, Bruno Garibaldi, Giuseppe A. Palumbo · 2022 · Journal of Clinical Medicine
51. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
    Cameron Grant McCarthy, Piu Saha, Rachel M. Golonka, Camilla Ferreira Wenceslau, Bina Joe, Matam Vijay–Kumar · 2021 · Comprehensive physiology
52. Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
    Hacer Kuzu Okur, Koray Yalçın, Cihan Taştan, Sevda Demir, Bulut Yurtsever, Gözde Sır Karakuş, Derya Dilek Kançağı, Selen Abanuz, Utku Seyis, Rehile Zengin et al. · 2020 · New Microbes and New Infections
53. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
    Mário Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas, Marcos V. Santana, Luiz Carlos Saramago Gonçalves, Lauro Ribeiro de Souza Neto, Sabrina Baptista Ferreira, Floriano Paes Silva · 2020 · Memórias do Instituto Oswaldo Cruz
54. D-dimer, Troponin, and Urea Level at Presentation With COVID-19 can Predict ICU Admission: A Single Centered Study
    Mahmood Yaseen Hachim, Ibrahim Y. Hachim, Kashif Naeem, Haifa Hannawi, Issa Al Salmi, Suad Hannawi · 2020 · Frontiers in Medicine
55. Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
    Jaykaran Charan, Siddhartha Dutta, Rimple Jeet Kaur, Pankaj Bhardwaj, Praveen Sharma, Sneha R. Ambwani, Iffat Jahan, Abdullahi Rabiu Abubakar, Salequl Islam, Timothy Craig Hardcastle et al. · 2021 · Expert Opinion on Drug Safety
56. Histone H3 Cleavage in Severe COVID-19 ICU Patients
    Joram Huckriede, Femke de Vries, Michael Hultström, Kanin Wichapong, Chris P.M. Reutelingsperger, Miklós Lipcsey, Pablo Garcı́a de Frutos, Robert Frithiof, Gerry A. F. Nicolaes · 2021 · Frontiers in Cellular and Infection Microbiology
57. Eleven Routine Clinical Features Predict COVID-19 Severity Uncovered by Machine Learning of Longitudinal Measurements
    Kai Zhou, Yaoting Sun, Lu Li, Zelin Zang, Jing Wang, Jun Li, Junbo Liang, Fangfei Zhang, Qiushi Zhang, Weigang Ge et al. · 2020 · Computational and Structural Biotechnology Journal
58. Phagocytosis and neutrophil extracellular traps
    Frank R. DeLeo, Lee‐Ann H. Allen · 2020 · Faculty Reviews
59. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections
    Ahmed-Hassan, Hanaa, Sisson, Brianna, Shukla, Rajni Kant, Wijewantha, Yasasvi, Funderburg, Nicholas T., Li, Zihai, Hayes, Don, Demberg, Thorsten, Liyanage, Namal P. M. · 2020 · Frontiers in Immunology
60. G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19)
    Hung‐Chi Yang, Tian‐Hsiang Ma, Wen-Ye Tjong, Arnold Stern, Daniel Tsun-Yee Chiu · 2021 · Free Radical Research
61. Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019
    Mieke Metzemaekers, Seppe Cambier, Marfa Blanter, Jennifer Vandooren, Ana Carolina de Carvalho, Bert Malengier‐Devlies, Lore Vanderbeke, Cato Jacobs, Sofie Coenen, Erik Martens et al. · 2021 · Clinical & Translational Immunology
62. Neutrophil-Dependent Immunity During Pulmonary Infections and Inflammations
    Clement Yaw Effah, Emmanuel Kwateng Drokow, Clement Agboyibor, Lihua Ding, Sitian He, Shaohua Liu, Senyo Yao Akorli, Emmanuel Nuamah, Tongwen Sun, Xiaolei Zhou et al. · 2021 · Frontiers in Immunology
63. The role of extracellular histones in COVID‐19
    Femke de Vries, Joram Huckriede, Kanin Wichapong, Chris P.M. Reutelingsperger, Gerry A. F. Nicolaes · 2022 · Journal of Internal Medicine
64. Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
    Janis Kay Shute · 2023 · Pharmaceuticals
65. Cellular sensing of extracellular purine nucleosides triggers an innate IFN-β response
    Rekha Dhanwani, Mariko Takahashi, Ian T. Mathews, Camille Lenzi, Artem Romanov, Jeramie D. Watrous, Bartijn C. H. Pieters, Catherine C. Hedrick, Chris A. Benedict, Joel M Linden et al. · 2020 · Science Advances
66. A Fragile Balance: Does Neutrophil Extracellular Trap Formation Drive Pulmonary Disease Progression?
    Helena Block, Alexander Zarbock · 2021 · Cells
67. The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
    Andreas Kronbichler, Duvuru Geetha, Rona Smith, Allyson C. Egan, Ingeborg M. Bajema, Ulf Schönermarck, Alfred Mahr, Hans‐Joachim Anders, Annette N. Bruchfeld, Maria Cinta Cid et al. · 2021 · Autoimmunity Reviews
68. Nanotechnology Applications of Flavonoids for Viral Diseases
    Khoshnur Jannat, Alok Kumar Paul, Tohmina Afroze Bondhon, Anamul Hasan, Muhammad Nawaz, Rownak Jahan, Tooba Mahboob, Veeranoot Nissapatorn, Polrat Wilairatana, Maria de Lourdes Pereira et al. · 2021 · Pharmaceutics
69. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells
    Sayed Ausim Azizi, Saara‐Anne Azizi · 2020 · Journal of NeuroVirology
70. Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19
    Kevan L. Hartshorn · 2020 · Frontiers in Cellular and Infection Microbiology
71. Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19
    Marine Peyneau, Vanessa Granger, Paul-Henri Wicky, Dounia Khelifi‐Touhami, JF Timsit, François-Xavier Lescure, Yazdan Yazdanpanah, Alexy Tran‐Dinh, Philippe Montravers, Renato C. Monteiro et al. · 2022 · Scientific Reports
72. SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure
    Alain Roger Thierry, Benoit Roch · 2020 · Clinical Science
73. COVID-19: Role of neutrophil extracellular traps in acute lung injury
    Ahmed Yaqinuddin, Peter R. Kvietys, Junaid Kashir · 2020 · Respiratory Investigation
74. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients
    Shubham Shrivastava, Shweta Chelluboina, Prashant Pandurang Jedge, Purwa Prakash Doke, Sonali Hemant Palkar, Akhilesh Chandra Mishra, Vidya Avinash Arankalle · 2021 · Frontiers in Cellular and Infection Microbiology
75. Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention
    Valery Danilenko, Andrey Devyatkin, Mariya Marsova, Madina Shibilova, Rustem Abuzarovich Ilyasov, Vladimir Shmyrev · 2021 · Journal of Inflammation Research
76. Neutrophils at the crossroads of acute viral infections and severity
    Surender Rawat, Sudhanshu Vrati, Arup Kumar Banerjee · 2021 · Molecular Aspects of Medicine
77. Functional food: complementary to fight against COVID-19
    Maisha Farzana, Sagarika Shahriar, Faria Rahman Jeba, Tahani Tabassum, Yusha Araf, Md. Asad Ullah, Jarin Tasnim, Agnila Chakraborty, Taslima Anjum Naima, Kay Kay Shain Marma et al. · 2022 · Beni-Suef University Journal of Basic and Applied Sciences
78. Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques
    Chrysi Keskinidou, Alice Georgia Vassiliou, Ioanna Dimopoulou, Αnastasia Kotanidou, Stylianos E. Orfanos · 2022 · Journal of Inflammation Research
79. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19
    Christopher M. Rice, Philip A. Lewis, Fernando M. Ponce-Garcia, Willem Gibbs, Sarah Groves, Drinalda Cela, Fergus Hamilton, David Arnold, Catherine J. Hyams, Elizabeth Oliver et al. · 2022 · Life Science Alliance
80. The interplay between neutrophils, complement, and microthrombi in COVID-19
    Yu Zuo, Yogendra M. Kanthi, Jason S. Knight, Alfred H.J. Kim · 2021 · Best Practice & Research Clinical Rheumatology
81. Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression
    Etienne Cavalier, Julien Guiot, Katharina Lechner, Alexander Dutsch, Mark Eccleston, Mariëlle Herzog, Thomas Bygott, Adrian Schomburg, Theresa Kathleen Kelly, Stefan Holdenrieder · 2021 · Frontiers in Molecular Biosciences
82. Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
    Anita Gupta, Gopal S. Gupta · 2021 · Molecular and Cellular Biochemistry
83. Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
    Daniella M. Mizurini, Eugênio Damaceno Hottz, Patrícia Torres Bozza, Robson Q. Monteiro · 2021 · Frontiers in Cardiovascular Medicine
84. SARS-CoV-2 infection and thrombotic complications: a narrative review
    Iraklis C. Moschonas, Alexandros D. Tselepis · 2021 · Journal of Thrombosis and Thrombolysis
85. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
    Bülent Kantarcıoğlu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Alfonso Javier Tafur, Eduardo Ramacciotti et al. · 2021 · Clinical and Applied Thrombosis/Hemostasis
86. Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19
    Clark D Russell, Asta Valanciute, Naomi N. Gachanja, Jillian Stephen, Rebekah Penrice-Randal, Stuart D. Armstrong, Sara Clohisey, Bo Wang, Wael Al Qsous, William A. Wallace et al. · 2021 · American Journal of Respiratory Cell and Molecular Biology
87. Protein Kinase C Isoforms Mediate the Formation of Neutrophil Extracellular Traps
    N.V. Vorobjeva, Yulia A. Dagil, Mikhail V. Pashenkov, Boris V. Pinegin, Boris V. Chernyak · 2022 · International Immunopharmacology
88. Targeting immunometabolism to treat COVID-19
    Shane M. O’Carroll, Luke A.J. O'Neill · 2021 · Immunotherapy Advances
89. Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
    Hernán F. Peñaloza, Janet S. Lee, Prabir Ray · 2021 · PLoS Pathogens
90. O Papel da Imunidade Inata na COVID-19
    Luiz Henrique Silva de Sordi, Isabela Sales Oliveira Magalhães, Daniela Abreu Casselhas, Mariléia Cháves Andrade · 2020 · REVISTA CIÊNCIAS EM SAÚDE
91. More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review
    Stefano D’Errico, Martina Zanon, Martina Montanaro, Davide Radaelli, Francesco Sessa, Giulio Di Mizio, Angelo Montana, Salvatore Corrao, Monica Salerno, Cristoforo Pomara · 2020 · Microorganisms
92. H2 Inhibits the Formation of Neutrophil Extracellular Traps
    Kohsuke Shirakawa, Eiji Kobayashi, Genki Ichihara, Hiroki Kitakata, Yoshinori Katsumata, Kazuhisa Sugai, Yoji Hakamata, Motoaki Sano · 2022 · JACC Basic to Translational Science
93. Neutrophil metabolomics in severe COVID-19 reveal GAPDH as a suppressor of neutrophil extracellular trap formation
    Yafeng Li, Jessica S. Hook, Ding Qing, Xue Xiao, Stephen S. Chung, Marcel Mettlen, Lin Xu, Jessica G. Moreland, Michalis Agathocleous · 2023 · Nature Communications
94. Oxidative stress and ROS-mediated cellular events in RSV infection: potential protective roles of antioxidants
    Xue Yang, Xue Liu, Yujun Nie, Fei Zhan, Bin Zhu · 2023 · Virology Journal
95. Metabolic regulation of neutrophil functions in homeostasis and diseases
    Pier-Olivier Leblanc, Sylvain G. Bourgoin, Patrice E. Poubelle, Philippe A. Tessier, Martin Pelletier · 2024 · Journal of Leukocyte Biology
96. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
    MA Haimei · 2020 · Clinical and Applied Thrombosis/Hemostasis
97. How NETosis could drive “Post-COVID-19 syndrome” among survivors
    Serge Aimé Sawadogo, Bonnie Dighero-Kemp, Dieu‐Donné Ouedraogo, Lisa E. Hensley, Jean Sakandé · 2020 · Immunology Letters
98. Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death
    David Dennison, Murtadha K. Al-Khabori, Sahimah Al‐Mamari, Allan Aurelio, Houda Al Hinai, Khuloud Al Maamari, Jalila Alshekaili, Ghalib Al Khadouri · 2021 · International Journal of Infectious Diseases
99. Resveratrol as an Adjunctive Therapy for Excessive Oxidative Stress in Aging COVID-19 Patients
    Min-Tser Liao, Chia‐Chao Wu, Shu‐Fang Vivienne Wu, Mei‐Chen Lee, Wan‐Chung Hu, Kuo‐Wang Tsai, Chung‐Hsiang Yang, Chien‐Lin Lu, Sheng-Kang Chiu, Kuo‐Cheng Lu · 2021 · Antioxidants
100. NETosis and SARS-COV-2 infection related thrombosis: a narrative review
     Mahin Behzadifard, Masoud Soleimani · 2022 · Thrombosis Journal